155 related articles for article (PubMed ID: 9578139)
1. Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats.
Valverde O; Roques BP
Neurosci Lett; 1998 Mar; 244(1):37-40. PubMed ID: 9578139
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.
Lu L; Huang M; Liu Z; Ma L
Neuroreport; 2000 Mar; 11(4):829-32. PubMed ID: 10757528
[TBL] [Abstract][Full Text] [Related]
5. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
Mosher JT; Johnson MF; Birkemo LS; Ervin GN
Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
[TBL] [Abstract][Full Text] [Related]
6. The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.
Higgins GA; Joharchi N; Wang Y; Corrigall WA; Sellers EM
Brain Res; 1994 Mar; 640(1-2):246-54. PubMed ID: 8004452
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
Ballaz S; Barber A; Fortuño A; Del Río J; Martin-Martínez M; Gómez-Monterrey I; Herranz R; González-Muñiz R; García-López MT
Br J Pharmacol; 1997 Jun; 121(4):759-67. PubMed ID: 9208145
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of CCK-B receptors involved in animal models of anxiety.
Derrien M; McCort-Tranchepain I; Ducos B; Roques BP; Durieux C
Pharmacol Biochem Behav; 1994 Sep; 49(1):133-41. PubMed ID: 7816864
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
[TBL] [Abstract][Full Text] [Related]
10. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
Léna I; Roques BP; Durieux C
J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722
[TBL] [Abstract][Full Text] [Related]
11. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
Sullivan AF; Hewett K; Dickenson AH
Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
[TBL] [Abstract][Full Text] [Related]
13. CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.
Lemaire M; Böhme GA; Piot O; Roques BP; Blanchard JC
Psychopharmacology (Berl); 1994 Aug; 115(4):435-40. PubMed ID: 7871086
[TBL] [Abstract][Full Text] [Related]
14. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
Crawley JN
J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
[TBL] [Abstract][Full Text] [Related]
15. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
Jagerschmidt A; Guillaume-Rousselet N; Vikland ML; Goudreau N; Maigret B; Roques BP
Eur J Pharmacol; 1996 Jan; 296(1):97-106. PubMed ID: 8720482
[TBL] [Abstract][Full Text] [Related]
16. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
Maldonado R; Valverde O; Derrien M; Tejedor-Real P; Roques BP
Pharmacol Biochem Behav; 1994 Jun; 48(2):363-9. PubMed ID: 8090802
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
[TBL] [Abstract][Full Text] [Related]
18. Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.
Yu H; Wen D; Ma C; Meng Y; Li S; Ni Z; Cong B
PLoS One; 2012; 7(7):e41860. PubMed ID: 22848639
[TBL] [Abstract][Full Text] [Related]
19. Failure of cholecystokinin to precipitate withdrawal in morphine-treated rats.
Pournaghash S; Riley AL
Pharmacol Biochem Behav; 1991 Mar; 38(3):479-84. PubMed ID: 2068185
[TBL] [Abstract][Full Text] [Related]
20. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
